text from the article: The Department of Defense announced eight defense contracts on Wednesday. Worth $198.4 million in total, the contracts ranged in value by a factor of 10 -- from as much as $80 million to as little as $7.7 million. Yet it was that very smallest of the eight contracts awarded yesterday that was the most interesting.
The Defense Advanced Research Projects Agency (DARPA) awarded Pfizer (NYSE:PFE) a $7.7 million contract to research whether it might be possible to "identify and subsequently induce the production of protective antibodies to an emerging pathogen directly in an infected or exposed individual."
